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(Needham et al., 2013), however most studies comparing telomere
length (TL) across racial/ethnic groups have found that in general Afri-
can-Americans tend to have longer telomeres than Whites (Hou et al.,
2015; Needham et al., 2013). This counterintuitive ﬁnding has led re-
searchers to hypothesize that these differences are due to genetic ances-
try, speciﬁcally polymorphisms related to genes that regulate TL, orTelomeres, tandem TTAGGG nucleotide repeats located at the ends
of eukaryotic chromosomes, are DNA-protein complexes critical to the
maintenance of genomic stability and cellular longevity. They are
among the most-studied markers of the aging process, with multiple
studies showing that telomeres shorten with age. This, in turn, has led
researchers to posit a relationship between telomere shortening and a
variety of age-related health conditions, particularly cancer. Many stud-
ies have identiﬁed associations between cancer risk andboth longer and
shorter telomeres (Hou et al., 2012), a contradiction that can potentially
be explained via a dynamic relationship over timewherein people early
in cancer development experience accelerated telomere shortening that
is subsequently arrested as cancer cells hijack various telomere length-
eningmechanisms (Hou et al., 2015). This process is believed to be nec-
essary not only for immortalizing cells, but also because it can be used to
delay cell senescence and thus provide opportunity for the accumula-
tion of additional mutations (via DNA damage or other processes) nec-
essary to complete the transformation into a cancerous cell (Noy, 2009).
The racial disparity in US rates of cancer (among other diseases) has
been well-characterized and continues to persist with African-Ameri-
cans having generally worse cancer incidence and mortality than
Whites (Siegel et al., 2015). While many researchers have identiﬁed
proximal causes for this disparity current research remains unable to
completely explain the frequent and dramatic differences in cancer
rates between US racial/ethnic subgroups, prompting researchers in
molecular epidemiology to undertake new studies of this problem.
Many of the risk factors thought to contribute to racial health disparities
in the US (e.g., socioeconomic status/health care access, stress, environ-m.2016.08.015.
Medicine, Feinberg School of
e Drive, Suite 1400, Chicago, IL
).
. This is an open access article undermental exposures) have also been associated with shorter telomeres
possibly unaccounted-for environmental factors such as pollutant expo-
sure (Scinicariello and Buser, 2015).
Previous studies, including genome-wide association studies (GWAS),
have identiﬁed numerous genes associated with TL throughmechanisms
including shelterin, DNA repair, helicases, and telomerase (Mirabello et
al., 2010) but few have explored variation in the expression of these
genes by race/ethnicity. In this issue of EBioMedicine, Hamad et al.
(Hamad et al., 2016) attempt to answer the question of genetic vs. envi-
ronmental interplay in racial TL differences via a cross-sectional explora-
tion of genes associated with TL and various sociodemographic
characteristics including race/ethnicity. Using genetic data from 11,141
participants in the Health and Retirement Study (HRS) collected in
2006 and 2008 they construct a polygenic risk score (PRS) of seven single
nucleotide polymorphisms following the method developed by Codd et
al. (Codd et al., 2013). They then identify racial and ethnic differences in
PRS, with African-Americans having a lower PRS (predicting longer telo-
meres) and Hispanics having higher PRS (predicting shorter telomeres)
compared toWhites. These ﬁndings were independent of socioeconomic
factors (education and total assets), age, and gender and conﬁrmed using
a genetic principal components approach with components strongly as-
sociated with race/ethnicity. Interestingly, self-reported race performed
nearly aswell as genetic ancestry for these telomere-associated polymor-
phisms. In a subset of 5808HRS participantswith available data on TL, the
authors also conﬁrmed longer telomeres in African-Americans, and in-
triguing associations between TL and select genetic principal compo-
nents. Data on individual SNPs presented in the supplementary tables
will also fuel future research.
These ﬁndings suggest that African-Americans share a genetic pre-
disposition to longer TL, andHispanics to shorter TL, and that these sub-
groups experience different rates of TL shortening over their lives
relative toWhites. Thus, observed differences in TL may be due to tradi-
tional risk factors (possibly other than socioeconomic status). This pro-
vides one possible explanation for the contradictory ﬁndings regardingthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
28 B.T. Joyce, L. Hou / EBioMedicine 11 (2016) 27–28race and TL elsewhere in the literature, but further research using telo-
mere-related clinical endpoints (e.g., cancer diagnosis) and speciﬁc ex-
posures is needed to establish clinical signiﬁcance for these ﬁndings. If
validated, telomeresmay be a useful tool for assessing health risks relat-
ed to racial/ethnic minority status in the US, and potentially for improv-
ing early diagnosis and/or prevention of the many age-related health
conditions driving the observed racial/ethnic health disparities. In addi-
tion, these results will need to be conﬁrmed in other populations (as
noted by the authors in their discussion of potential survivorship bias
in the HRS). Nonetheless, these ﬁndings provide new insight into the
trajectory of telomere shortening over time in multiple demographic
subgroups. Conﬁrming via longitudinal studies the distribution of the
genetic determinants of TL in the US population could greatly enhance
our understanding of the epidemiology of age-related diseases and
lead to breakthroughs in new personalized detection and prevention
efforts.
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